March 26, 2020March 27, 2020
FDA Approves Zeposia (Ozanimod), Oral Therapy for All with Relapsing MS
News, SPMS
The U.S. Food and Drug Administration (FDA) has approved Zeposia (ozanimod) oral capsules to treat adults with relapsing forms ... Read more
April 6, 2020April 6, 2020
MS News that Caught My Eye Last Week: Exercise, Diet, and Myelin
Columns, The MS Wire - A Column by Ed Tobias
Regular Exercise ‘Strongly Recommended’ to Ease Fatigue in MS This may seem like a no-brainer. But once upon a ... Read more
April 6, 2020April 6, 2020
Study Finds Link Between Secondhand Smoke Exposure in Adolescence and MS Risk
News
People exposed to secondhand cigarette smoke during adolescence may be more likely to develop multiple sclerosis (MS) later in ... Read more
April 6, 2020April 6, 2020
Biogen’s Plegridy or Avonex Use Possible in Pregnancy, Breastfeeding, FDA Says
News
Plegridy (peginterferon beta-1a) and Avonex (interferon beta-1a), both by Biogen, may be used — if necessary — ... Read more
April 3, 2020March 31, 2020
How to Make Working from Home Work for You
A Life in Letters – a Column by Jamie Hughes, Columns
I just finished my third week of working from home due to the coronavirus, and I’ve learned a few ... Read more
April 3, 2020March 31, 2020
In Training for Solitary Confinement
Columns, Fall Down, Get Up Again- a Column by John Connor
I’ve just been sentenced to at least 18 months in solitary without time off even for good behavior! Pretty ... Read more
April 3, 2020April 1, 2020
Neurologists Turn to Telemedicine During Coronavirus Sheltering
Columns, The MS Wire - A Column by Ed Tobias
Dr. Aaron Boster assessed the gait of his multiple sclerosis patient, who walked forward and back. Earlier, he had ... Read more
April 3, 2020April 3, 2020
Headache a Common Side Effect of Interferon-beta Treatment, Study Finds
News
New or worsening headaches are a more common side effect of interferon-beta (IFN-beta) treatment in people with multiple sclerosis (MS) ... Read more
April 3, 2020April 3, 2020
Ocrevus Lowers Progression Risk in More Disabled MS Patients, Study Suggests
News
For multiple sclerosis (MS) patients with considerable disability, Ocrevus (ocrelizumab) appears to lower the risk of continued ... Read more
April 2, 2020March 30, 2020
That Time When MS Left Me at a Loss for Words
Columns, MS in Moderation – a Column by Tamara Sellman
Editor’s note: This week’s column is inspired by the forum topic “7 Strange and Unusual Symptoms of Multiple Sclerosis” ... Read more
April 2, 2020March 31, 2020
I’m Choosing to Let My Spirit Shine During the COVID-19 Crisis
Columns, Silver Linings - a Column by Jennifer Powell
We are living in unprecedented times. Years from now, references will be made to COVID-19. Numbers of those afflicted ... Read more
April 2, 2020April 3, 2020
Regular Exercise ‘Strongly Recommended’ to Ease Fatigue in MS
News
Physical exercise can ease fatigue in people with multiple sclerosis (MS) and potentially benefit them in many other ways, ... Read more
April 2, 2020April 2, 2020
Diets of MS Patients in Spain Seen to Favor Fats, Proteins and Inflammation
News
A study from Spain found the diet of multiple sclerosis (MS) patients to contain more fat and protein, and fewer ... Read more

April 6, 2020April 6, 2020

Study Finds Link Between Secondhand Smoke Exposure in Adolescence and MS Risk

News

People exposed to secondhand cigarette smoke during adolescence may be more likely to develop multiple sclerosis (MS) later in life, a study suggests. The study, “Exposure to passive smoking ... Read more

April 6, 2020April 6, 2020

Biogen’s Plegridy or Avonex Use Possible in Pregnancy, Breastfeeding, FDA Says

News

Plegridy (peginterferon beta-1a) and Avonex (interferon beta-1a), both by Biogen, may be used — if necessary — by women with relapsing multiple sclerosis who are pregnant or breastfeeding, the U.S. Food ... Read more

April 3, 2020April 3, 2020

Headache a Common Side Effect of Interferon-beta Treatment, Study Finds

News

New or worsening headaches are a more common side effect of interferon-beta (IFN-beta) treatment in people with multiple sclerosis (MS) than previously appreciated, a new study suggests. The study, “Interferon-Beta-Induced ... Read more

April 3, 2020April 3, 2020

Ocrevus Lowers Progression Risk in More Disabled MS Patients, Study Suggests

News

For multiple sclerosis (MS) patients with considerable disability, Ocrevus (ocrelizumab) appears to lower the risk of continued progression in both relapsing and primary progressive forms of the disease, data from ... Read more

April 2, 2020April 3, 2020

Regular Exercise ‘Strongly Recommended’ to Ease Fatigue in MS

News

Physical exercise can ease fatigue in people with multiple sclerosis (MS) and potentially benefit them in many other ways, and should be part of rehabilitation programs for patients, a ... Read more

April 2, 2020April 2, 2020

Diets of MS Patients in Spain Seen to Favor Fats, Proteins and Inflammation

News

A study from Spain found the diet of multiple sclerosis (MS) patients to contain more fat and protein, and fewer carbohydrates, than recommended, which was linked to abdominal weight gain ... Read more

April 1, 2020April 1, 2020

Biosimilar Truxima Works as Well as Rituximab Originator in MS, Study Finds

News

Truxima, a biosimilar of rituximab, is comparable to the originator therapy in terms of effectiveness and safety for treating multiple sclerosis (MS), a new study suggests. Rituximab — marketed as Rituxan in the United ... Read more

April 1, 2020April 1, 2020

Blood Levels of Nerve Cell Protein Likely Marker of Brain Injury to Come

News

A nerve cell protein found in the blood shows potential as a biomarker of neuroinflammation and future neurodegeneration in the early stages of multiple sclerosis (MS), a study reports. The ... Read more

March 31, 2020March 31, 2020

Canada Rules EHP-101, Potential Cannabidiol Treatment, Not Controlled Substance

News

EHP-101, a cannabidiol-derived investigational therapy being developed by Emerald Health Pharmaceuticals (EHP) to treat multiple sclerosis (MS), is not a controlled substance in Canada, the company announced. The active ingredient in ... Read more

March 31, 2020March 31, 2020

Bile Acid Supplements May Ease Symptoms of Progressive MS

News

Multiple sclerosis (MS) patients have lower than usual levels of molecules called bile acids circulating in their blood, a study found. These molecules, produced in the liver to aid fat ... Read more

March 30, 2020March 31, 2020

CHMP Favors Zeposia (Ozanimod) as Oral Treatment for Active RRMS in EU

News

The Committee for Medicinal Products for Human Use (CHMP) has recommended Zeposia (ozanimod) oral capsules to be approved in the European Union (EU) to treat adults with active relapsing-remitting multiple sclerosis ... Read more

March 30, 2020April 2, 2020

Way of Getting Nerve Cells to Restore Myelin-like Abilities Seen as Possible

News

Researchers developed a way of reprograming cells to use synthetic materials — provided by the team — to create artificial, working structures within or about the cells. This approach ... Read more

March 27, 2020March 27, 2020

Mix of Broad and Specific Language May Help in Talking About MS

News

Using a mix of broad diagnostic terms and more disease-specific ones may help physicians and patients to better communicate symptoms of autoimmune disorders like multiple sclerosis (MS) that are not always ... Read more

March 27, 2020March 27, 2020

Potential Competitor to Acthar Gel Asking to Re-enter US Market

News

ANI Pharmaceuticals is asking the U.S. Food and Drug Administration (FDA) for the right to reintroduce in the U.S. market its Cortrophin Gel (repository corticotropin injection, 80 U/ml) to ... Read more

March 26, 2020March 30, 2020

Helius Medical Technologies Authorized by Heath Canada to Market PoNS Device

News

The neurotechnology company Helius Medical Technologies has received authorization from Health Canada to market its portable neuromodulation stimulator (PoNS) device to treat gait deficit in patients with mild-to-moderate multiple sclerosis (MS). ... Read more

March 26, 2020March 27, 2020

FDA Approves Zeposia (Ozanimod), Oral Therapy for All with Relapsing MS

News, SPMS

The U.S. Food and Drug Administration (FDA) has approved Zeposia (ozanimod) oral capsules to treat adults with relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS (RRMS), active secondary progressive MS (SPMS), and ... Read more

March 25, 2020March 25, 2020

Myelin Health Depends on Steady Supply of Lipids, Study Suggests

News

Continuous production of fatty molecules (lipids) is crucial to the maintenance of the myelin sheath that wraps nerve fibers to protect them, ensuring the transmission of electrical impulses between ... Read more

March 25, 2020March 25, 2020

‘Talk’ Therapy Helps with Insomnia and Fatigue in MS, Trial Suggests

News

Cognitive behavioral therapy, a type of “talk” therapy, may help ease the severity of insomnia, fatigue, and anxiety in people with multiple sclerosis (MS), improving the quality of their ... Read more